The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration

Thyroid. 2009 Jul;19(7):673-4. doi: 10.1089/thy.2009.0169.
No abstract available

Publication types

  • Congress
  • News

MeSH terms

  • Adult
  • Antithyroid Agents / adverse effects
  • Antithyroid Agents / therapeutic use*
  • Female
  • Graves Disease / drug therapy*
  • Humans
  • Liver Failure / chemically induced
  • Methimazole / adverse effects
  • Methimazole / therapeutic use
  • Pregnancy
  • Propylthiouracil / adverse effects
  • Propylthiouracil / therapeutic use*
  • Societies, Medical
  • United States
  • United States Food and Drug Administration

Substances

  • Antithyroid Agents
  • Methimazole
  • Propylthiouracil